Results 261 to 270 of about 370,325 (328)

Predictive Factors of Early Super-Response to Biologic Agents in Psoriasis: Insights from Real-World Evidence. [PDF]

Clin Cosmet Investig Dermatol
Koç Yıldırım S, Ayyıldız SM, Demirel Öğüt N, Erbağcı E, Ünal S, Gokyayla E.   +5 more
europepmc   +1 more source

Effects of Overload on Imiquimod-Induced Psoriasis Model Mice: A Basic Experimental Study. [PDF]

Health Sci Rep
Furutani T, Saito T, Ikeda A, Mashima K, Yukihiro N, Kusakabe S, Nakamichi R, Yoshida A, Nishida K, Ozaki T.   +9 more
europepmc   +1 more source

Dupilumab‐Associated Palmar Erythema Successfully Treated With Fluconazole

Australasian Journal of Dermatology, EarlyView.
Katina J. Selvaraj, Geoffrey Lee
wiley   +1 more source

Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction

Clinical Otolaryngology, EarlyView.
ABSTRACT Objectives Tumour Necrosis factor antagonists is a potent anti‐inflammatory medication and has shown to improve olfactory function in murine models. The primary aim was to determine the effect of TNF antagonists on olfactory performance in humans.
Andreas Espehana, George Macfarlane, Elizabeth Mairenn Garden, Liam Lee, Gabija Klyvyte, Lavandan Jegatheeswaran, Rebecca Davies, Carl Philpott   +7 more
wiley   +1 more source

Activation of unfolded protein response pathways promotes keratinocyte differentiation and ameliorates psoriasis phenotypes. [PDF]

Cell Stress Chaperones
Zhang Z, Tan M, Liu X, Wang W, Chen X, Peng C, Zhao S, Wu L.   +7 more
europepmc   +1 more source

Real‐Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study

Contact Dermatitis, EarlyView.
From January 2024 to May 2025, 207 patients (68.6% females) affected by CHE were enrolled to be clinically and etiologically investigated using a case report form specifically developed. The accurate workup led to clinical and etiological classification of CHE in about 80% of patients, allowing tailored treatment strategies. ABSTRACT Background Chronic
Rosella Gallo, Fabrizio Guarneri, Katharina Hansel, Luca Stingeni, Maddalena Napolitano, Cataldo Patruno, Monica Corazza, Alessandro Borghi, Ilaria Trave, Emanuela Martina, Maria Michela Lauriola, Rosanna Rita Satta, Caterina Foti, Paolo Romita, Roberta Giuffrida, Silvia Mariel Ferrucci, on behalf of SIDAPA CHE Study Group, Gabriele Biondi, Gabriele Casciola, Florenzia Marielli, Roberto Pinto, Ilaria Salvi   +21 more
wiley   +1 more source

TLR9/MyD88/NF-κB signaling mediates mental stress-induced exacerbation of psoriasis through immune dysregulation in a mouse model. [PDF]

PLoS One
Song Q, Li D, Yuan Z, Zhang C, Wang J, Liao F, Xu P, Xiao Q.   +7 more
europepmc   +1 more source

Effect of Delgocitinib Cream on Health‐Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema

Contact Dermatitis, EarlyView.
Patient‐reported outcomes are an important complement to physician‐assessed clinical outcome measures in Chronic Hand Eczema. In a pooled analysis of two randomised, controlled trials, twice‐daily treatment with delgocitinib cream 20 mg/g significantly improved the health‐related quality of life of patients with moderate to severe Chronic Hand Eczema ...
Andrea Bauer, Lyn Guenther, Richard Woolf, Eydna Didriksen Apol, Douglas Maslin, Nanna Nyholm, Henrik Thoning, Marie Louise Schuttelaar   +7 more
wiley   +1 more source

Evaluation of chemerin levels in the pathogenesis of psoriasis. [PDF]

Front Med (Lausanne)
Matwiejuk M, Kulczyńska-Przybik A, Łukaszuk B, Myśliwiec H, Myśliwiec P, Chabowski A, Mroczko B, Flisiak I.   +7 more
europepmc   +1 more source

Interleukin‐22 and Interleukin‐18 as Potential Blood Biomarkers in Dupilumab‐Treated Atopic Dermatitis

Allergy, EarlyView.
Ayano Fukushima‐Nomura, Hiroshi Kawasaki, Takehiro Hasegawa, Erika Yanagisawa, Keiji Tanese, Nozomi Yanagida, Shoko Obata, Kiyoshi Yashiro, Yoshihiro Ito, Haruhiko Koseki, Masayuki Amagai   +10 more
wiley   +1 more source